Abstract:Objective To analyze the detection efficiency of non-sex dependent Ras association domain family 1A (RASSF1A) sequences in maternal plasma as a fetal epigenetic marker,and to explore the feasibility of replacing SRY gene in quantitative detection of fetal free DNA.Methods Maternal peripheral blood samples were collected in the first,second and third trimester from 50 normal pregnant women who had their prenatal care in the First and Fifth People's Hospital in Datong,Shanxi Province,between May 1,2011 and April 30,2012.Among them,pregnant women with single male fetus (n=28) were selected as study group,and another 20 normal healthy non-pregnant women in the same period were selected as control.The methylationsensitive restriction enzymes were used specifically to cut the maternal hypomethylated RASSF1A gene,the fetal hypermethylated sequences were determined by fluorescence quantitative polymerase chain reaction,and SRY sequences in maternal plasma were determined as a reference.Shapiro-wilk,Pearson or Spearman correlation analysis and Chi-square test were applied for statistical analysis.Results Among the 28 pregnant women with male fetus,the hypermethylated RASSF1A sequences in maternal plasma was tested 84 times and identified as early as at 8+2 weeks of gestation,giving the detection rate of 97.62％ (82/84).However,no RASSF1A or SRY gene was identified in control group.The mean concentrations of hypermethylated RASSF1A and SRY gene in the first,second and third trimester group were (60.19± 14.16) copies/ml vs (58.22± 15.13) copies/ml (r=0.933,P＜0.01),(99.18±28.44) copies/ml vs (95.43±32.33) copies/ml (r=0.931,P＜0.01)and (144.93±33.51) copies/ml vs (132.96±28.24) copies/ml (r=0.654,P＜0.01),respectively.The mean concentrations of hypermethylated RASSF1A and SRY gene showed positive correlation with gestational weeks (r=0.933 and 0.896,P＜0.01,respectively).Conclusions By using hypermethylated RASSF1A gene as an epigenetic marker,the detected free fetal DNA results is highly consistent with SRY gene without gender influence.Thus,it is helpful to expand its clinical application of noninvasive prenatal diagnosis.

Hypomethylated Dscr4 Is A Placenta-Derived Epigenetic Marker For Trisomy 21

Differentially methylated regions of C21orf25 between maternal and fetal DNA:implication for noninvasive prenatal diagnosis

Methylation difference of DSCR4 gene between maternal and fetal and its clinical value

Non-invasive Prenatal Diagnosis of Trisomy 21 by Dosage Ratio of Fetal Chromosome-Specific Epigenetic Markers in Maternal Plasma

Noninvasive Prenatal Diagnosis Implication of Differentially Methylated DNA in Noninvasive Prenatal Diagnosis.

Noninvasive Prenatal Testing of Trisomies 21 and 18 by Massively Parallel Sequencing of Maternal Plasma DNA in Twin Pregnancies.

DNA Methylome Profiling of Maternal Peripheral Blood and Placentas Reveal Potential Fetal DNA Markers for Non-Invasive Prenatal Testing.

Detectionof Fetal Trisomy 8 Mosaicism with Cell-free Fetal DNA in Maternal Plasma

Microarray Based DNA Methylation Assay in Maternal Plasma of Pregnant Women

Value of detecting free fDNA in maternal plasma in Down′s syndrome screening

Screening of Potential Biomarkers for Prenatal Diagnosis of Trisomy 21

Microarray-Based Method to Analyze DNA Methylation of Maternal Plasma in Pregnant Women

Screening Significantly Hypermethylated Genes in Fetal Tissues Compared with Maternal Blood Using a Methylated-Cpg Island Recovery Assay-Based Microarray

Detection of Cell-Free Fetal Mrna in Maternal Plasma for a New Prenatal Screening Marker of Down' S Syndrome.

Placental DNA Methylation Abnormalities in Prenatal Conotruncal Heart Defects

Quantification of Fetal DNA by Using Methylation-Based Discrimination

Prenatal Diagnosis of Trisomy 8 Mosaicism, Initially Identified by Cffdna Screening

Placental Delta-Like 1 Gene DNA Methylation Levels Are Related to Mothers’ Blood Glucose Concentration

Detection Efficiency of Fetal Epigenetic Marker in Maternal Plasma

Noninvasive Prenatal Detection of Down Syndrome: Are We Finally Getting the Right Message?

Alteration in Methylation Level at Differential Methylated Regions of MEST and DLK1 in Fetus of Preeclampsia.